US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.515
  • -0.003-0.62%
Trading Apr 29 11:36 ET
106.78MMarket Cap-347P/E (TTM)

Sangamo Therapeutics Key Stats

Sangamo Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

2.04M

-92.50%
EPS(YoY)

-0.34

-6.25%

Buy

Mar 31, 2024

Sangamo Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 7.718M--
--2024/Q1-- / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--
Aug 8, 20232023/Q26.835M / 15.333M--
Apr 26, 20232023/Q1157.957M / 105.864M--
Feb 22, 20232022/Q427.230M / 26.856M--
Nov 3, 20222022/Q326.460M / 26.787M--
Aug 4, 20222022/Q229.378M / 24.629M--
May 5, 20222022/Q128.231M / 27.286M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 7.718M--
--2024/Q1-- / 6.361M--
--2023/Q42.042M / 8.105M--
Nov 1, 20232023/Q39.398M / 10.404M--
Aug 8, 20232023/Q26.835M / 15.333M--
Apr 26, 20232023/Q1157.957M / 105.864M--
Feb 22, 20232022/Q427.230M / 26.856M--
Nov 3, 20222022/Q326.460M / 26.787M--
Aug 4, 20222022/Q229.378M / 24.629M--
May 5, 20222022/Q128.231M / 27.286M--

Unlock Free Earnings Estimates

Sangamo Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    57.14%
  • Hold

    42.86%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg